Adam33 polymorphisms are associated with COPD and lung function in long-term tobacco smokers

[1]  E. Bleecker,et al.  IL13 promoter polymorphism 1112C/T modulates the adverse effect of tobacco smoking on lung function. , 2007, American journal of respiratory and critical care medicine.

[2]  C. Lemière,et al.  Increased expression of ADAM33 and ADAM8 with disease progression in asthma. , 2007, The Journal of allergy and clinical immunology.

[3]  Cleo C. van Diemen,et al.  A Disintegrin and Metalloprotease 33 polymorphisms and lung function decline in the general population , 2006, European Respiratory Review.

[4]  J Vestbo,et al.  Developing COPD: a 25 year follow up study of the general population , 2006, Thorax.

[5]  S. Weiland,et al.  The role of polymorphisms in ADAM33, a disintegrin and metalloprotease 33, in childhood asthma and lung function in two German populations , 2006, Respiratory research.

[6]  D. Duffy,et al.  ADAM33 haplotypes are associated with asthma in a large Australian population , 2006, European Journal of Human Genetics.

[7]  K. Tokunaga,et al.  ADAM33 polymorphisms are associated with asthma susceptibility in a Japanese population , 2006, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[8]  D. Postma,et al.  A disintegrin and metalloprotease 33 polymorphisms and lung function decline in the general population. , 2005 .

[9]  A. Woodcock,et al.  Polymorphisms in a disintegrin and metalloprotease 33 (ADAM33) predict impaired early-life lung function. , 2005, American journal of respiratory and critical care medicine.

[10]  I. Hall,et al.  Contribution of ADAM33 polymorphisms to the population risk of asthma , 2005, Thorax.

[11]  S. Holgate,et al.  The discovery and role of ADAM33, a new candidate gene for asthma , 2004, Expert Reviews in Molecular Medicine.

[12]  Dirkje S Postma,et al.  Rationale for the Dutch hypothesis. Allergy and airway hyperresponsiveness as genetic factors and their interaction with environment in the development of asthma and COPD. , 2004, Chest.

[13]  E. Bleecker,et al.  Similarities and differences in asthma and COPD. The Dutch hypothesis. , 2004, Chest.

[14]  Deborah A Meyers,et al.  Genetics of asthma and COPD. Similar results for different phenotypes. , 2004, Chest.

[15]  H. Shin,et al.  ADAM33 polymorphism: association with bronchial hyper‐responsiveness in Korean asthmatics , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[16]  E. Silverman,et al.  ADAM33 polymorphisms and phenotype associations in childhood asthma. , 2004, The Journal of allergy and clinical immunology.

[17]  D. Postma,et al.  Polymorphisms of the ADAM33 gene are associated with accelerated lung function decline in asthma , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[18]  E. Bleecker,et al.  Changing patterns in asbestos-induced lung disease. , 2004, Chest.

[19]  H. Gohlke,et al.  Asthma is associated with single‐nucleotide polymorphisms in ADAM33 , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[20]  P. Kwok,et al.  ADAM33 is not associated with asthma in Puerto Rican or Mexican populations. , 2003, American journal of respiratory and critical care medicine.

[21]  D. Postma,et al.  Association of a disintegrin and metalloprotease 33 (ADAM33) gene with asthma in ethnically diverse populations. , 2003, The Journal of allergy and clinical immunology.

[22]  Steuart Rorke,et al.  Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness , 2002, Nature.

[23]  D. Schaid,et al.  Score tests for association between traits and haplotypes when linkage phase is ambiguous. , 2002, American journal of human genetics.

[24]  N. Orie,et al.  The dutch hypothesis , 2000, Chest.

[25]  John L. Hankinson,et al.  Standardization of Spirometry, 1994 Update. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[26]  B. Make,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[27]  W. Bailey,et al.  Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. , 1995, JAMA.

[28]  R. Klocke,et al.  THE AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE , 1994 .

[29]  A. Buist,et al.  The Lung Health Study. Baseline characteristics of randomized participants. , 1993, Chest.

[30]  Buist As.  Standardization of spirometry. , 1987 .

[31]  Phillips Yy,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. , 1987, The American review of respiratory disease.

[32]  R. Peto,et al.  The natural history of chronic airflow obstruction. , 1977, British medical journal.

[33]  R. Lewontin,et al.  THE INTERACTION OF SELECTION AND LINKAGE. II. OPTIMUM MODELS. , 1964, Genetics.

[34]  R. Lewontin.  The Interaction of Selection and Linkage. I. General Considerations; Heterotic Models. , 1964, Genetics.